Women's Hospital School Of Medicine Zhejiang University
Phase
Observational
Started
2023-09-15
Last updated
2025-07-17
Condition(s) studied
Cervical CancerEndometrial Cancer
Investigational drug(s) / intervention(s)
No intervention
No intervention: This is a prospective observational study with no intervention.
Study summary
The purposes of current study were to explore the relationship between cervical cancer/endometrial cancer and demographic information, behavior and life style, pregnancy-related factors, and disease history, and to study the factors affecting the prognosis of cancers. In addition, omics tests were performed on the biological specimens to identify the diagnostic markers and prognostic biomarkers.
Eligibility
Sex
FEMALE
Min age
20 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria:
* Age 20-75 years;
* Women with cervical cancer or endometrial cancer with a definite pathological diagnosis for the first time;
* Women attending a health check-up;
* Obtain informed consent and sign an informed consent form.
Exclusion Criteria:
* Patients who are unable to cooperate with the investigations such as mental disorders or cognitive impairment；
* Patients with cancer other than cervical cancer or endometrial cancer;
* Women who have received hysterectomy or pelvic radiation therapy previously.
Primary outcome measure(s)
progression free survival (PFS) — 60 months progression free survival for patients with cervical cancer or endometrial cancer
Trial sites (1)
Facility
City
Region
Status
Women's hospital school of medicine zhejiang university
Hangzhou
Zhejiang
Recruiting
More Women's Hospital School Of Medicine Zhejiang University trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.